Sema7A binding to PlexinC1 mediates tumor growth (Scott et al., 2009), while Sema7A binding to integrin β1 initiates T-lymphocyte-mediated inflammatory-immune response (Suzuki et al., 2007). This evidence concerns the gene SEMA7A and neoplasm.